Table 4:
Results of linear regression models predicting cycle threshold (Ct) value from the HIV diagnostic total nucleic acid PCR test
| Univariate Each covariate on their own predicting Ct In whole population (N=316) |
Multivariable All covariates shown entered simultaneously into a model predicting Ct In those VL <50 copies/mL at time of test (N=288) |
Multivariable All covariates shown entered simultaneously into a model predicting Ct In ESRU only and VL <50 copies/mL at time of test (N=211) |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Parameter estimate | Standard error | p-value | Parameter estimate | Standard error | p-value | Parameter estimate | Standard error | p-value | |
| Age at ART start (months) | −0.106 | 0.018 | <0.0001 | −0.115 | 0.018 | <0.0001 | −0.104 | 0.018 | <0.0001 |
| VL sustained <400 copies/mL during CHANGES (Yes vs. No) | 1.804 | 0.214 | <0.0001 | 1.572 | 0.227 | <0.0001 | 1.371 | 0.241 | <0.0001 |
| Ever treated with EFV (Yes vs. No) | 0.633 | 0.235 | 0.007 | 0.563 | 0.238 | 0.019 | 0.576 | 0.294 | 0.051 |
| CD4+ T-cell count (cells/mm3) at PCR test (divided by 100) | −0.029 | 0.037 | 0.426 | −0.104 | 0.038 | 0.006 | −0.098 | 0.038 | 0.010 |
| Site (ESRU vs. PHRU) | 0.403 | 0.265 | 0.130 | 0.504 | 0.264 | 0.057 | - | - | - |
| VL <50 copies/mL at test | 2.345 | 0.387 | <0.0001 | - | - | - | - | - | - |